𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF-7 MIII human breast cancer xenografts in nude mice

✍ Scribed by Shirahige, Y.; Cai, R.-Z.; Szepeshazi, K.; Halmos, G.; Pinski, J.; Groot, K.; Schally, A.V.

Book ID
123568460
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
725 KB
Volume
48
Category
Article
ISSN
0753-3322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of somatostatin analog RC-160 and
Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice
✍ Jacek Pinski; Andrew V. Schally; Gabor Halmos; Karoly Szepeshazi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 679 KB

## Abstract Nude mice bearing xenografts of the androgen‐independent human prostate‐cancer cell line PC‐3 were treated for 4 weeks with somatostatin analog RC‐160, bombesin/gastrin‐releasing peptide (GRP) antagonist (RC‐3095), or the combination of both peptides. In the first experiment, treatment

Inhibition of growth of MKN45 human gast
Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160
✍ Jucek Pinski; Gabor Halmos; Tetsu Yano; Karoly Szepeshazi; Yunfeng Qin; Tibor Er 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 853 KB

## Abstract Nude mice bearing xenografts of the gastrin‐responsive human gastric carcinoma MKN45 cell line were treated for 4 to 5 weeks with bombesin/gastrin‐releasing‐peptide(GRP) antagonist (RC‐3095), somatostatin analogues RC‐160 and SMS 201‐995, or the combination of RC‐3095 and RC‐160. Tumor